Surgical Robots
Surgical robotics is led by a handful of large medtech incumbents, with Intuitive Surgical, Medtronic, Johnson & Johnson and Stryker the main named players, and a smaller entrant, SS Innovations, pursuing wider market access. The newest development in the confirmed record is Stryker's robotics alliance with CMR Surgical. The main risks are China demand and tendering, tariff costs, and regulatory gating for new entrants. Confirmed data on component enablers is thin.
Active institutional funds added a net $808.8 million in Q2 2026, versus $1.0 billion in Q1 2026 — an inflow 21% smaller. 75% of companies in this sub-theme saw increased active positions in Q2 2026.
Overview
Surgical robots are robotic-assisted systems that help surgeons perform precision procedures. They are sold as capital platforms to hospitals and surrounded by instruments, planning tools and integrated operating-room equipment. The competitive field is concentrated. Intuitive Surgical, Medtronic and Johnson & Johnson are described as larger, well-established competitors in robotically controlled surgical products. Stryker participates through its Mako robotic-assisted joint replacement platform. SS Innovations competes with its SSi Mantra system and names Intuitive, Medtronic, Johnson & Johnson and Samsung as rivals. Adjacent relationships extend the ecosystem beyond the robot itself. Baxter supplies an operating-room table integrated with da Vinci robotic arms. Materialise provides planning services and 3D-printed surgical guides that Medtronic, Stryker, Smith & Nephew and Zimmer Biomet distribute. Harmonic Drive Systems is classified as an enabler, but no confirmed relationships, activity or constraints are on record for it, so its role cannot be described from the confirmed data.
Investment Thesis
Investment thesis details are part of the Pro plan.
Bottleneck Tracker
Bottleneck details are part of the Pro plan.